{"": [99, 107, 0, 108, 1245, 0], "Introduction": [1246, 4702, 0], "Multiple occurrences and transmission of spike \u0394H69/V70 with and without spike mutations": [4712, 5738, 0], "\u0394H69/V70 is not a neutralizing antibody escape mechanism": [5739, 8042, 0], "\u0394H69/V70 spike enhances infectivity associated with increased cleaved S incorporation": [8043, 11177, 0], "Enhanced infectivity of \u0394H69/V70 spike is not correlated with cleavage or entry route": [11178, 14118, 0], "\u0394H69/V70 spike compensates for reduced infectivity of RBD escape mutants": [14119, 16891, 0], "\u0394H69/V70 is required for optimal B.1.1.7 Alpha variant spike S2 incorporation and infectivity": [16892, 19932, 0], "Alpha variant B.1.1.7 spike mediates faster syncytium formation and is \u0394H69/V70 dependent": [19933, 21373, 0], "\u0394H69/V70 does not enhance infectivity of bat coronavirus RaTG13 spike": [21374, 24278, 0], "Results": [4703, 24278, 1], "Limitations": [31676, 34414, 0], "Discussion": [24279, 34414, 1], "Consortia": [34415, 48295, 0], "Key resources table": [48310, 48335, 0], "Lead contact": [48359, 48493, 0], "Materials availability": [48494, 48567, 0], "Data and code availability": [48568, 48673, 0], "Resource availability": [48336, 48673, 1], "Ethical approval": [49171, 49350, 0], "Experimental model and subject details": [48674, 49350, 1], "Phylogenetic analysis": [49367, 51401, 0], "Structural modeling": [51402, 52060, 0], "RNA secondary structure modeling": [52061, 52380, 0], "Cells": [52381, 52822, 0], "Pseudotype virus preparation": [52823, 53935, 0], "SARS-CoV-2 D614 (Wuhan) and RaTG13 mutant plasmids and infectivity": [53936, 54982, 0], "Standardization of virus input by SYBR green-based product-enhanced PCR assay (SG-PERT)": [54983, 55973, 0], "Generation of coronavirus-like particles and western blotting": [55974, 58360, 0], "Spike cleavage inhibition experiments": [58361, 59274, 0], "Cell-cell fusion assay": [59275, 60248, 0], "Western blotting": [60249, 61721, 0], "Serum pseudotype neutralization assay": [61722, 62537, 0], "Monoclonal antibody neutralization of B.1.1.7 or B.1.1.7 H69/V70 pseudotyped viruses": [62538, 64313, 0], "Ab discovery and recombinant expression": [64314, 65035, 0], "Pseudovirus neutralization assay for testing NTD monoclonal antibodies": [65036, 66507, 0], "Neutralization assays": [66508, 67714, 0], "Method details": [49351, 67714, 1], "Quantification and statistical analysis": [67715, 68096, 0], "STAR\u2605Methods": [48296, 68096, 1]}